Stanzen Life Sciences Private Limited
About Stanzen Life Sciences Private Limited
Data last updated:
Stanzen Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2018PTC127006. Its GSTIN is 36ABACS8500M1Z5 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhagavan Reddy Kamireddy and Nitya Kamireddy.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 7 – 102/36 Plot No – 36 201 2nd Floor Sai Srinivasa Residency Habsiguda, Hyderabad, Telangana, India – 500007.
Company details
Contact details
Stanzen Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address7 – 102/36 Plot No – 36 201 2nd Floor Sai Srinivasa Residency Habsiguda, Hyderabad, Telangana, India – 500007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stanzen Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Stanzen Life Sciences Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Stanzen Life Sciences Private Limited, buy the company report.
Board of directors of Stanzen Life Sciences Private Limited
Stanzen Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhagavan Reddy Kamireddy | Director | 21 Sep 2018 | 8 Years 1 Months | Current |
| Nitya Kamireddy Also directs: Stanex Drugs and Chemicals Private Limited | Director | 01 Jun 2023 | 3 Years 4 Months | Current |
Auditor
Stanzen Life Sciences Private Limited is audited by V C MOULI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V C MOULI & CO | FY 2019 | 006349S |
Shareholding
The shareholding of Stanzen Life Sciences Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Stanzen Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Stanzen Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stanzen Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stanzen Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABACS8500M1Z5 | Telangana | Active | 17 Dec 2018 |
To see the full GST registrations and return filing status of Stanzen Life Sciences Private Limited, buy the company report.
Recent activity
Stanzen Life Sciences Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Osama Ashraf Abdul Hafeez ceased to be Director on 28 Jun 2023.
Frequently asked questions
Stanzen Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 September 2018 (8+ years old) and is registered under CIN U24299TG2018PTC127006.
Stanzen Life Sciences has 2 current directors:
- Bhagavan Reddy Kamireddy - Director
- Nitya Kamireddy - Director
The latest financial statements of Stanzen Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Stanzen Life Sciences is 36ABACS8500M1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of Stanzen Life Sciences is U24299TG2018PTC127006. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stanzen Life Sciences was incorporated on 21 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Osama Ashraf Abdul Hafeez ceased to be Director on 28 Jun 2023. Nitya Kamireddy was appointed as Director on 01 Jun 2023. Bhagavan Reddy Kamireddy was appointed as Director on 21 Sep 2018.
The registered office of Stanzen Life Sciences is at 7 – 10236 Plot No – 36 201 2nd Floor Sai Srinivasa Residency Habsiguda, Hyderabad, Telangana, India – 500007.
Stanzen Life Sciences operates in the pharma industry, in the drug formulation and development segment.
Stanzen Life Sciences can be reached at its registered office: 7 – 10236 Plot No – 36 201 2nd Floor Sai Srinivasa Residency Habsiguda, Hyderabad, Telangana, India – 500007.